Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of the β-Lactamase Inhibitor Vaborbactam (RPX7009) in Healthy Adult Subjects

Por Griffith, David C., Loutit, Jeffery S., Morgan, Elizabeth E., Durso, Stephanie, Dudley, Michael N.
Publicado no Antimicrob Agents Chemother (2016)

Pharmacokinetics and Safety of MP-376 (Levofloxacin Inhalation Solution) in Cystic Fibrosis Subjects

Por Geller, David E., Flume, Patrick A., Griffith, David C., Morgan, Elizabeth, White, Dan, Loutit, Jeffery S., Dudley, Michael N.
Publicado em 2011

Carbapenem-Resistant Enterobacteriaceae Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical Trials

Por Alexander, Elizabeth L., Loutit, Jeffery, Tumbarello, Mario, Wunderink, Richard, Felton, Tim, Daikos, George, Fusaro, Karen, White, Dan, Zhang, Shu, Dudley, Michael N.
Publicado no Open Forum Infect Dis (2017)

Effects of Oritavancin on Coagulation Tests in the Clinical Laboratory

Por Belley, Adam, Robson, Richard, Francis, John L., Adcock, Dorothy M., Tiefenbacher, Stefan, Rubino, Christopher M., Moeck, Greg, Sylvester, David, Dudley, Michael N., Loutit, Jeffery
Publicado no Antimicrob Agents Chemother (2017)